FDA Inspection 1224863 — Rose BioSolutions Memphis LLC

Rose BioSolutions Memphis LLC — FEI 3006500433

The FDA completed an inspection of Rose BioSolutions Memphis LLC on Nov 17, 2023 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 17, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Memphis, TN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.